Breneman, A., Bowling, A., Trager, M. H., Gordon, E. R., Arron, S. T., & Samie, F. H. (2025). Sebaceous carcinoma in immunosuppressed patients: a narrative review. Archives of Dermatological Research, 317(1). https://doi.org/10.1007/s00403-024-03710-w

Theodore, D. A., Henneman, A. D., Loo, A., Shields, R. K., Eschenauer, G., Sobieszczyk, M. E., & Kubin, C. J. (2024). Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia. Journal of Antimicrobial Chemotherapy, 79(8), 1877–1884. https://doi.org/10.1093/jac/dkae175

Greninger, A. L., Rybkina, K., Lin, M. J., Drew-Bear, J., Marcink, T. C., Shean, R. C., Makhsous, N., Boeckh, M., Harder, O., Bovier, F., Burstein, S. R., Niewiesk, S., Rima, B. K., Porotto, M., & Moscona, A. (2021). Human parainfluenza virus evolution during lung infection of immunocompromised individuals promotes viral persistence. Journal of Clinical Investigation, 131(23). https://doi.org/10.1172/jci150506

Stonesifer, C. J., Trager, M. H., Magro, C. M., & Geskin, L. J. (2021). CD8+ Lymphogranulomatous Dermatitis as a Manifestation of Malignancy-Associated Immunodeficiency: Rethinking Paraneoplastic Granulomas. The American Journal of Dermatopathology, 43(12), e222–e226. https://doi.org/10.1097/dad.0000000000002068